These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. Vymazal J, Spuentrup E, Cardenas-Molina G, Wiethoff AJ, Hartmann MG, Caravan P, Parsons EC. Invest Radiol; 2009 Nov; 44(11):697-704. PubMed ID: 19809344 [Abstract] [Full Text] [Related]
3. Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent. Spuentrup E, Katoh M, Buecker A, Fausten B, Wiethoff AJ, Wildberger JE, Haage P, Parsons EC, Botnar RM, Graham PB, Vettelschoss M, Günther RW. Invest Radiol; 2007 Aug; 42(8):586-95. PubMed ID: 17620942 [Abstract] [Full Text] [Related]
4. Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model. Spuentrup E, Katoh M, Wiethoff AJ, Buecker A, Botnar RM, Parsons EC, Guenther RW. Rofo; 2007 Nov; 179(11):1166-73. PubMed ID: 17948194 [Abstract] [Full Text] [Related]
5. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent. Spuentrup E, Buecker A, Katoh M, Wiethoff AJ, Parsons EC, Botnar RM, Weisskoff RM, Graham PB, Manning WJ, Günther RW. Circulation; 2005 Mar 22; 111(11):1377-82. PubMed ID: 15738354 [Abstract] [Full Text] [Related]
6. Molecular magnetic resonance imaging of atrial clots in a swine model. Spuentrup E, Fausten B, Kinzel S, Wiethoff AJ, Botnar RM, Graham PB, Haller S, Katoh M, Parsons EC, Manning WJ, Busch T, Günther RW, Buecker A. Circulation; 2005 Jul 19; 112(3):396-9. PubMed ID: 16009790 [Abstract] [Full Text] [Related]
8. Molecular magnetic resonance imaging of deep vein thrombosis using a fibrin-targeted contrast agent: a feasibility study. Katoh M, Haage P, Wiethoff AJ, Günther RW, Bücker A, Tacke J, Spuentrup E. Invest Radiol; 2009 Mar 19; 44(3):146-50. PubMed ID: 19151606 [Abstract] [Full Text] [Related]
10. Molecular MRI of intracranial thrombus in a rat ischemic stroke model. Uppal R, Ay I, Dai G, Kim YR, Sorensen AG, Caravan P. Stroke; 2010 Jun 19; 41(6):1271-7. PubMed ID: 20395615 [Abstract] [Full Text] [Related]
12. Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent. Spuentrup E, Katoh M, Wiethoff AJ, Parsons EC, Botnar RM, Mahnken AH, Günther RW, Buecker A. Am J Respir Crit Care Med; 2005 Aug 15; 172(4):494-500. PubMed ID: 15937292 [Abstract] [Full Text] [Related]
17. High spatial resolution and high contrast visualization of brain arteries and veins: impact of blood pool contrast agent and water-selective excitation imaging at 3T. Spuentrup E, Jacobs JE, Kleimann JF, Wiethoff AJ, Poggenborg J, Brinker G, Loehr M, Möller-Hartmann W, Botnar RM, Ernestus RI, Lackner KJ. Rofo; 2010 Dec 15; 182(12):1097-104. PubMed ID: 20803412 [Abstract] [Full Text] [Related]
18. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Botnar RM, Perez AS, Witte S, Wiethoff AJ, Laredo J, Hamilton J, Quist W, Parsons EC, Vaidya A, Kolodziej A, Barrett JA, Graham PB, Weisskoff RM, Manning WJ, Johnstone MT. Circulation; 2004 Apr 27; 109(16):2023-9. PubMed ID: 15066940 [Abstract] [Full Text] [Related]
19. Fibrin-targeted contrast agent for improvement of in vivo acute thrombus detection with magnetic resonance imaging. Sirol M, Aguinaldo JG, Graham PB, Weisskoff R, Lauffer R, Mizsei G, Chereshnev I, Fallon JT, Reis E, Fuster V, Toussaint JF, Fayad ZA. Atherosclerosis; 2005 Sep 27; 182(1):79-85. PubMed ID: 16115477 [Abstract] [Full Text] [Related]